Market Cap

TerrAscend Corp Market Capitalization:

C$804.8 Million

CAD as of July 1, 2023

US$607.4 Million

business TerrAscend Corp Company Profile

TerrAscend Corp Main Stock Listings

Market Capitalization History of TerrAscend Corp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of TerrAscend Corp market cap

Date Market Cap YoY Change
Jan. 1, 2023 C$686.5 M -69.44%
Jan. 1, 2022 C$2.25 B -57.82%
Jan. 1, 2021 C$5.33 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

TerrAscend Corp Categories

Canada languages Healthcare languages Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Stocks & Indices

TerrAscend Corp has the following listings and related stock indices.


Stock: TSX: TSND

Stock: CSE: TER

Stock: FSX: TED

Stock: OTC: TRSSF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.